UniQure, Syndax, Erasca Drawing Fresh Analyst Interest
Three clinical-stage biotechs—UniQure, Syndax, and Erasca—are catching analyst attention ahead of key catalysts, with...
Explore what are the standard benefits of credit cards to enhance your financial knowledge. Understand these essentials for better use.
12,702 articlesThree clinical-stage biotechs—UniQure, Syndax, and Erasca—are catching analyst attention ahead of key catalysts, with...
The DOJ settlement with Live Nation aims to boost competition and transparency in ticketing, but analysts warn it may...
Two tech giants just reported blowout results. This guide breaks down what the numbers mean and how to decide which g...
Roughly 1 in 5 adults suffer from chronic pain, rising with age. This report outlines 12 non-drug therapies and how f...
Leveraged Ether funds like ETHU are amplifying Ethereum moves even as crypto volatility spikes and regulators weigh a...
Two AI infrastructure players, CoreWeave and Nebius, face off as compute demand climbs. This guide breaks down backlo...
Understanding runway growth (rway) earnings helps you assess whether a young company can sustain momentum. Learn key ...
As markets wobble in 2026, five stalwarts stand out for reliable income and resilience. Here are the safest dividend ...
Home prices remain elevated while supply nudges higher. A new builders’ blueprint tackle housing outlines pragmatic s...
Is micron stock now? A thoughtful, numbers-informed look at memory demand, AI-driven growth, and how to decide if Mic...
ServiceNow faces AI disruption head-on, arguing its execution platform creates a durable moat even as shares slide. C...
UniCredit announces a $40 billion bid for Germany’s second-largest bank with a 4% premium, but early signals point to...